Nevada has agreed to back a proposed nationwide settlement worth up to $26 billion resolving lawsuits against three large drug distributors and the drugmaker Johnson & Johnson over the deadly U.S. opioid epidemic, the state’s attorney general said on Tuesday. …
NEW YORK–Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a setback for a company still facing thousands of other opioid-related lawsuits around the United States. The verdict, which followed a nearly six-month …
The Oklahoma Supreme Court on Tuesday overturned a $465 million judgment against Johnson & Johnson in a lawsuit by the state alleging the drugmaker fueled the opioid epidemic through the deceptive marketing of painkillers. The decision marked the latest setback …
The three largest U.S. drug distributors will pay more than $75 million to resolve claims they fueled an opioid epidemic in the Cherokee Nation’s territory in Oklahoma, marking the first settlement with a tribal government in the litigation over the …
Drugmaker Endo International Plc on Thursday said it has agreed to pay $50 million to resolve lawsuits by New York state and two of its largest counties related to the sale and marketing of opioids. Endo said the settlement includes …
CHARLESTON, W.Va. — Lawyers for a West Virginia city and county hard hit by the opioid crisis began wrapping up their case in a $2.5 billion trial on Tuesday arguing major drug distributors flooded the region with the addictive pills, …
NEW YORK, July 20 (Reuters) – The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid …
HUNTINGTON, W.Va. (AP) — A 15-year plan to abate the opioid crisis in a West Virginia community will cost local officials $2.5 billion, a forensic economist has testified. George Barrett testified Tuesday that Cabell County and the city of Huntington …
Opioid suppliers including Teva Pharmaceutical Industries Ltd. and McKesson Corp. began their defense of claims the industry is liable for an epidemic of addiction by telling a New York jury there’s no proof they did anything wrong. Drug makers and …
McKinsey & Co.’s role in assisting companies profiting from opioid-based painkillers was “far more extensive” than just advising makers of the highly addictive medicines, according to an Indian tribe’s newly filed lawsuit. Besides advising manufacturers such as Johnson & Johnson …